Latest Breaking News On - Brian carrico - Page 4 : vimarsana.com

Baystreet ca - This Could Help Treat Post-Concussion Syndrome in Children

Every year, an estimated 1.6 million to 3.8 million sports- and recreation-related concussions are seen, as noted by the Brain Injury Research Institute (BIRI), adding that, “During 2001-2005, children and youth ages 5-18 years accounted for 2.4 .

United statesAbbott alinityBrian carricoIntegra lifesciencesBrain injury research instituteNational institutes of healthOdyssey health incAbbott laboratoriesDrug administrationNeuraxis incLook at neuraxis incOdyssey healthProspective studyPost concussion syndromeChief executive officerImmediate post concussion assessment

This Could Help Treat Post-Concussion Syndrome In Children

This Could Help Treat Post-Concussion Syndrome In Children
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesBrian carricoIntegra lifesciencesAbbott alinityLook at neuraxis incDrug administrationBrain injury research instituteNational institutes of healthNeuraxis incOdyssey health incAbbott laboratoriesCould help treat post concussion syndromeFor exampleProspective studyPost concussion syndromeChief executive officer

Carmel startup NeurAxis raises $6 6M in IPO – Inside INdiana Business

Carmel startup NeurAxis raises $6 6M in IPO – Inside INdiana Business
insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.

Brian carricoJohn russellYork stock exchangeDrug administrationNew york stock exchangeInnovative health solutions incExchange commissionIndianapolis businessNew york stockInnovative health solutions

Carmel startup NeurAxis raises $6 6M in IPO, less than half of its original forecast – Indianapolis Business Journal

The company, which is developing electrical-nerve stimulation therapies for children, went public this month at an initial price of $6 a share lower than the range of $7 to $9 a share it announced in February.

Brian carricoNew york stock exchangeYork stock exchangeDrug administrationInnovative health solutions incExchange commissionNew york stockInnovative health solutions

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue

NeurAxis Announces Over $8 Million in IB-Stim™ Revenue
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBrian carricoCompanyneuraxis incNeuraxis incExchange commissionInvestor relationsgilmartin groupChief executive officerLooking statementsthisInc neuraxisPercutaneous electrical nerve field stimulation